A detailed history of Darden Wealth Group Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Darden Wealth Group Inc holds 1,460 shares of LLY stock, worth $1.13 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares
1,460
Previous 1,460 -0.0%
Holding current value
$1.13 Million
Previous $1.14 Billion 16.38%
% of portfolio
0.8%
Previous 0.89%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$592.2 - $792.28 $59,220 - $79,228
100 Added 7.35%
1,460 $1.14 Billion
Q4 2023

Feb 12, 2024

BUY
$525.19 - $619.13 $714,258 - $842,016
1,360 New
1,360 $793 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $738B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Darden Wealth Group Inc Portfolio

Follow Darden Wealth Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Darden Wealth Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Darden Wealth Group Inc with notifications on news.